Home Reimbursed medicines Rituximab
Rituximab — maximum prices and reimbursement
The CANAMED catalogue contains 16 medicines with the active substance Rituximab, from 6 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Rituximab there are 16 authorised medicines in the CANAMED catalogue, with maximum retail prices between 633.93 and 8085.71 RON, from 6 manufacturers. For 12 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Rituximab
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| RUXIENCE 100mg | PFIZER MANUFACTURING BELGIUM NV - BELGIA | 633.93 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~633.93 RON; you ~0.00 RON* |
PR |
| RIXATHON 100 mg | SANDOZ GMBH - AUSTRIA | 1128.60 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~1128.60 RON; you ~0.00 RON* |
PR |
| TRUXIMA 100 mg | MILLMOUNT HEALTHCARE LTD. - IRLANDA | 1565.76 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~1325.45 RON; you ~240.31 RON* |
PR |
| RIXATHON 100 mg | SANDOZ GMBH - AUSTRIA | 1656.81 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~1656.81 RON; you ~0.00 RON* |
PR |
| MABTHERA 100 mg | ROCHE PHARMA AG - GERMANIA | 1674.35 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~1325.45 RON; you ~348.90 RON* |
PR |
| RIXATHON 500 mg | SANDOZ GMBH - AUSTRIA | 2772.04 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~2772.04 RON; you ~0.00 RON* |
PR |
| RUXIENCE 500mg | PFIZER MANUFACTURING BELGIUM NV - BELGIA | 2968.43 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~2968.43 RON; you ~0.00 RON* |
PR |
| TRUXIMA 500 mg | MILLMOUNT HEALTHCARE LTD. - IRLANDA | 4039.00 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~3282.96 RON; you ~756.04 RON* |
PR |
| MABTHERA 500 mg | ROCHE PHARMA AG - GERMANIA | 4158.48 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~3282.96 RON; you ~875.52 RON* |
PR |
| RIXATHON 500 mg | SANDOZ GMBH - AUSTRIA | 5471.60 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~5471.60 RON; you ~0.00 RON* |
PR |
| MABTHERA 1400 mg | ROCHE PHARMA AG - GERMANIA | 7083.96 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~7083.96 RON; you ~0.00 RON* |
PR |
| MABTHERA 1600 mg | ROCHE PHARMA AG - GERMANIA | 8085.71 RON | 100% · C1 (certain chronic diseases) · and C2 CNAS pays ~8085.71 RON; you ~0.00 RON* |
PR |
| ITUXREDI 100mg | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | — | not reimbursed | PR |
| ITUXREDI 100mg | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | — | not reimbursed | PR |
| ITUXREDI 500mg | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | — | not reimbursed | PR |
| ITUXREDI 500mg | BETAPHARM ARZNEIMITTEL GMBH - GERMANIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
Live pharmacy prices
Products with Rituximab in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Rivaroxaban
- Rosuvastatin
- Ruxolitinib
- Ramipril
- Rivastigmin
- Ropinirol
- Risperidon
- Repaglinid
- Rabeprazol
- Rotigotin
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Rituximab
-
Is Rituximab reimbursed?
Yes. For 12 of the catalogue entries with Rituximab we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Rituximab?
The maximum retail prices (the CANAMED legal cap) for medicines with Rituximab are between 633.93 and 8085.71 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Rituximab is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Rituximab are in the CANAMED catalogue?
The CANAMED catalogue holds 16 authorised medicines with the active substance Rituximab — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go